1. Home
  2. STAA vs CSTL Comparison

STAA vs CSTL Comparison

Compare STAA & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$17.45

Market Cap

867.9M

Sector

Health Care

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$25.75

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
CSTL
Founded
1982
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
867.9M
806.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
STAA
CSTL
Price
$17.45
$25.75
Analyst Decision
Hold
Strong Buy
Analyst Count
9
6
Target Price
$22.19
$47.17
AVG Volume (30 Days)
1.2M
396.6K
Earning Date
03-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$239,442,000.00
$344,229,000.00
Revenue This Year
$33.83
$2.42
Revenue Next Year
$8.16
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$14.69
$14.59
52 Week High
$30.81
$44.28

Technical Indicators

Market Signals
Indicator
STAA
CSTL
Relative Strength Index (RSI) 43.95 28.81
Support Level $17.13 $24.89
Resistance Level $18.19 $34.97
Average True Range (ATR) 0.96 1.05
MACD 0.00 0.13
Stochastic Oscillator 22.26 16.96

Price Performance

Historical Comparison
STAA
CSTL

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: